Table 2

Patient and disease characteristics at entrance into BRASS cohort for subjects with ≥2 years of follow-up, in remission at one or more visit to any remission definition, and not in remission at entrance

N = 394

n (%)/Median (IQR)

Female

320 (81)

Age (years)

56 (45-63)

Positive anti-CCP or RF status

282 (72)

Smoking

24 (6)

Disease duration (years)

8 (2-19)

Any stiffness

286 (73)

Stiffness duration (minutes)

30-60 (10-90)

CRP (mg/L)

2.7 (1.1-7.9)

NSAIDs

244 (62)

Corticosteroids

103 (26)

MTX

196 (50)

Nonbiologic DMARDs

(not MTX)

137 (35)

Biologics

133 (34)

CCP, cyclic citrullinated peptide; CRP, C-reactive protein; DMARD, disease-modifying antirheumatic drug; MTX, methotrexate; RF, rheumatoid factor.

Prince et al. Arthritis Research & Therapy 2012 14:R68   doi:10.1186/ar3785